Landscape and Saturation Analysis of Mutations Associated With Race in Cancer Genomes by Clinical Sequencing

Oncologist. 2024 Jan 31:oyad341. doi: 10.1093/oncolo/oyad341. Online ahead of print.ABSTRACTDifferences in cancer genomes between racial groups may impact tumor biology and health disparities. However, the discovery of race-associated mutations is constrained by the limited representation and sample size of different racial groups in prior genomic studies. We evaluated the influence of race on the frequency of gene mutations using the Genomics, Evidence, Neoplasia, Information, Exchange database, a large genomic dataset aggregated from clinical sequencing. Matched cohort analyses were used to identify histology-specific race-associated mutations including increased TERT promoter mutations in Black and Asian patients with gliomas and bladder cancers, and a decreased frequency of mutations in DNA repair pathway genes and subunits of the SWI/SNF chromatin complex in Asian and Black patients across multiple cancer types. The distribution of actionable mutations in oncogenes was also race-specific, demonstrating how targeted therapies may have a disparate impact on racial groups. Down-sampling analyses indicate that larger sample sizes are likely to discover more race-associated mutations. These results provide a resource to understand differences in cancer genomes between racial groups which may inform the design of clinical studies and patient recruitment strategies in biomarker trials.PMID:38297963 | DOI:10.1093/oncolo/oyad341

Source: The Oncologist - February 1, 2024 Category: Cancer & Oncology Authors: Maishara Muquith David Hsiehchen Source Type: research